Phase II Study of Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors.
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2017
At a glance
- Drugs Bevacizumab (Primary) ; Doxorubicin (Primary) ; Fluorouracil (Primary) ; Streptozocin (Primary)
- Indications Endocrine gland neoplasms; Pancreatic cancer
- Focus Therapeutic Use
- 18 Aug 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 09 Mar 2008 New trial record.